(Q44680495)

5 December 2017

title

Must patients with advanced cancer choose between a Phase I trial and hospice? (English)

1 reference

5 December 2017

main subject

phase I clinical trial

0 references

author name string

David J Casarett

1

1 reference

5 December 2017

Jason H T Karlawish

2

1 reference

5 December 2017

Michelle I Henry

3

1 reference

5 December 2017

Karen B Hirschman

4

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

5 December 2017

1 reference

5 December 2017

volume

95

1 reference

5 December 2017

issue

7

1 reference

5 December 2017

page(s)

1601-1604

1 reference

Responses and toxic deaths in phase I clinical trials

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10820

Perceptions of cancer patients and their physicians involved in phase I trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10820

Informed consent, cancer, and truth in prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10820

Phase I cancer trials. A collusion of misunderstanding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10820

Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10820

Patient motivation and informed consent in a phase I study of an anticancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10820

Patients with cancer referred to hospice versus a bridge program: patient characteristics, needs for care, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10820

Cancer care during the last phase of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10820

inferred from DOI database lookup

7 January 2021

based on heuristic

Response rates, duration of response, and dose response effects in phase I studies of antineoplastics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10820

inferred from DOI database lookup

7 January 2021

based on heuristic

Opportunities for promoting palliative medicine in cancer research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10820

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.10820

1 reference

5 December 2017

1 reference